Skip to main content

#151881

Anti-S100A9 [6G4]

Cat. #151881

Anti-S100A9 [6G4]

Cat. #: 151881

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: S100A9

Class: Monoclonal

Application: ELISA ; Fn

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Nancy Hogg

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-S100A9 [6G4]
  • Research fields: Cancer;Cell signaling and signal transduction;Immunology
  • Clone: 6G4
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 14 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; Fn
  • Description: Major neutrophil protein; heterodimeric with S100-A8; roles in innate immunity and cancer
  • Immunogen: Recombinant MRP-14 (S100A9) Protein
  • Isotype: IgG1
  • Recommended controls: Neutrophils

Target Details

  • Target: S100A9
  • Molecular weight: 14 kDa
  • Tissue cell line specificity: Neutrophils
  • Target background: Major neutrophil protein; heterodimeric with S100-A8; roles in innate immunity and cancer

Applications

  • Application: ELISA ; Fn

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -20° C
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.